product image
Biogen seeks the FDA approval to revive its Alzheimer’s drug Aducanumab

Jun 26, 2020

Not a long time ago this year, Biogen announced the halting of Phase III clinical trials, EMERGE and ENAGE, of its most looked upon drug aducanumab under simulations for th...

Read More
product image
FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis

Feb 14, 2020

The US FDA today has given its nod to Trikafta (elexacaftor/ivacaftor/tezacaftor) of Vertex Pharmaceuticals, the first of its kind triple combination therapy for the patien...

Read More
product image
Emerging drugs bring a positive shift in Global Osteoporosis Market

Feb 6, 2020

Osteoporosis is not RARE. As per the International Osteoporosis Foundation (IOF), Osteoporosis affects an estimated 75 million people in Europe, USA and Japan. Approximatel...

Read More
product image
EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achillion Pharmaceuticals; Ipsen adds another drug to its rare disease pipeline

Feb 14, 2020

EicOsis has received USD 15Million grant from the National Institute of Drug Abuse (NIDA) to fund the clinical trials of non-opioid pain therapy. NIDA, with an aim to suppl...

Read More
product image
ImaginAb joins hands with AstraZeneca, Pfizer, Takeda

Jun 29, 2020

ImaginAb has collaborated with AstraZeneca, Pfizer and Takeda to develop technology to facilitate tumour imaging and monitoring inside the cells. ImaginAb is an emerging im...

Read More
product image
HR-positive/ HER2-negative Breast Cancer Market Insights: Upcoming Therapies and Market Analysis

Jul 20, 2020

Breast cancer is a serious and most common problem in developed as well as developing countries.About 1 in 8 U.S. women summing up to 12% are at the risk of developing inva...

Read More
product image
Global Burden of Liver cancer: Is it rising? 

Feb 5, 2020

Liver Cancer incidence is not as high as the incidence of breast or lung cancer. However, rising diagnosis rates reveal another story. According to a survey, Liver cancer h...

Read More
product image
First oral GLP-1 treatment approved for type2 Diabetes

Jun 29, 2020

The US FDA has approved Rybelsus (semaglutide) oral tablets to improve blood sugar in adult patients with Type II Diabetes. Rybelsus is an oral glucagon-like peptide (GLP-1...

Read More
product image
A New Era for Migraine Treatment and CGRP antibodies

Jun 26, 2020

The World Health Organization’s disability rating for migraine ranks it as the 19th most common reason for disability. According to the Migraine Trust Organization, Migra...

Read More
product image
FDA is reviewing a dangerous way to treat Peanut Allergy

Feb 5, 2020

Peanut allergies (PA) are the most common and severe type of food allergies in children. Even a small fragment of this legume to an allergic person can result in permanent ...

Read More
product image
Roche’s Tecentriq combo proves effective in Bladder cancer

Jun 29, 2020

Roche’s Genentech has presented positive Phase III results from the IMvigor130 study aimed at studying Tecentriq (atezolizumab) tested in combination with platinum-based ...

Read More
product image
STipe raises USD 22M; FDA approves Darzalex for multiple myeloma

Jun 29, 2020

Stipe Therapeutics (STipe) has raised USD 22 Million to move forward its clinical development of novel candidates to target intracellular protein-protein interactions of th...

Read More
product image
Cystic Fibrosis Drug Market: Emerging drugs that may improve lung infections

Sep 27, 2019

Cystic fibrosis (CF) manifests as a clinical syndrome characterized by chronic sinopulmonary infection as well as by gastrointestinal, nutritional, and other abnormalities....

Read More
product image
EU’s labels Nirogacestat an Orphan drug; FDA Approves First Smallpox, Monkeypox Vaccine; Evotec and Takeda collaborates to discover clinical candidates

Feb 14, 2020

European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma. Nirogacestat is a selective oral small molecule, gamma-secreta...

Read More
product image
Hyperthyroidism Treatment Market and Drugs

Sep 25, 2019

Hypoparathyroidism is a rare endocrine condition marked by low-calcium and high-phosphate levels as compared to a normally lower or inappropriate level of normal Parathyroi...

Read More